InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-7.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Barrage Khalil, Director. Director active across 1 company, notably Protagenic Therapeutics, Inc.\new. Aggregated, 2 filings have been logged. History available since 3 May 2021. The latest transaction was disclosed on 3 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
45,000 shares@ US$1.2550.0% of flowProtagenic Therapeutics, Inc. Common StockSEC:0001493152-21-010465
45,000 shares@ US$1.253.96% mcap50.0% of flowProtagenic Therapeutics, Inc. Common StockSEC:0001493152-21-010465:0
2 of 2 declarations
About Barrage Khalil
Khalil Barrage is a Board Member at Protagenic Therapeutics, Inc. He contributes to the governance of the company, bringing his expertise in strategy and leadership. His role is essential for guiding strategic decisions and ensuring compliance with industry standards.
